Stocks · Health care · Pharmaceutical Preparations

Xeris Biopharma Holdings, Inc.

XERS Clue Score53
United States Fiscal year ends December CIK 0001867096 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Beth Hecht
2 Feb 2026
See Remarks
Sell
16,667
$7.45
$124.15K
John Johnson
19 Dec 2025
Director
Sell
135,400
$7.22
$977.02K

What was left out

Form 4 filings counted 47
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 32
Sales straight out of an exercise 2
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 2,454,291
History held since 5 Oct 2021